IRADIMED CORP's ticker is IRMD and the CUSIP is 46266A109. A total of 62 filers reported holding IRADIMED CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $176,460 | +8.3% | 3,977 | +16.5% | 0.00% | – |
| Q2 2023 | $162,984 | -10.7% | 3,414 | -26.4% | 0.00% | – |
| Q1 2023 | $182,427 | +94.7% | 4,636 | +40.0% | 0.00% | – |
| Q4 2022 | $93,697 | -4.4% | 3,312 | +1.5% | 0.00% | – |
| Q3 2022 | $98,000 | -9.3% | 3,262 | +2.5% | 0.00% | – |
| Q2 2022 | $108,000 | -32.5% | 3,183 | -10.7% | 0.00% | – |
| Q1 2022 | $160,000 | -12.6% | 3,564 | -10.2% | 0.00% | – |
| Q4 2021 | $183,000 | +44.1% | 3,971 | +5.0% | 0.00% | – |
| Q3 2021 | $127,000 | +12.4% | 3,781 | -1.4% | 0.00% | – |
| Q2 2021 | $113,000 | +10.8% | 3,836 | -3.1% | 0.00% | – |
| Q1 2021 | $102,000 | +4.1% | 3,958 | -8.3% | 0.00% | – |
| Q4 2020 | $98,000 | +48.5% | 4,318 | +40.1% | 0.00% | – |
| Q3 2020 | $66,000 | +1.5% | 3,081 | +10.5% | 0.00% | – |
| Q2 2020 | $65,000 | +97.0% | 2,789 | +82.2% | 0.00% | – |
| Q1 2020 | $33,000 | -67.0% | 1,531 | -64.6% | 0.00% | – |
| Q4 2019 | $100,000 | +127.3% | 4,322 | +93.5% | 0.00% | – |
| Q3 2019 | $44,000 | -37.1% | 2,234 | -37.1% | 0.00% | – |
| Q2 2019 | $70,000 | -48.5% | 3,551 | -27.8% | 0.00% | – |
| Q1 2019 | $136,000 | +22.5% | 4,918 | +7.1% | 0.00% | – |
| Q4 2018 | $111,000 | -80.0% | 4,594 | -69.3% | 0.00% | – |
| Q3 2018 | $555,000 | -68.5% | 14,965 | -82.4% | 0.00% | -100.0% |
| Q2 2018 | $1,762,000 | +640.3% | 85,003 | +411.6% | 0.00% | – |
| Q1 2018 | $238,000 | -31.8% | 16,616 | -28.1% | 0.00% | – |
| Q4 2017 | $349,000 | +1354.2% | 23,100 | +820.3% | 0.00% | – |
| Q3 2017 | $24,000 | -40.0% | 2,510 | -46.3% | 0.00% | – |
| Q2 2017 | $40,000 | +2.6% | 4,674 | +3.0% | 0.00% | – |
| Q1 2017 | $39,000 | -46.6% | 4,539 | -32.6% | 0.00% | – |
| Q4 2016 | $73,000 | -79.1% | 6,737 | -67.4% | 0.00% | – |
| Q3 2016 | $350,000 | +204.3% | 20,688 | +289.0% | 0.00% | – |
| Q2 2016 | $115,000 | +18.6% | 5,318 | +4.1% | 0.00% | – |
| Q1 2016 | $97,000 | +1.0% | 5,108 | +46.2% | 0.00% | – |
| Q4 2015 | $96,000 | +10.3% | 3,494 | -2.4% | 0.00% | – |
| Q3 2015 | $87,000 | +8.8% | 3,580 | +3.1% | 0.00% | – |
| Q2 2015 | $80,000 | +142.4% | 3,474 | +56.5% | 0.00% | – |
| Q1 2015 | $33,000 | – | 2,220 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 140,752 | $3,290,000 | 3.17% |
| RK Capital | 222,914 | $5,212,000 | 1.95% |
| Nine Ten Capital Management LLC | 130,272 | $3,046,000 | 0.76% |
| Parkman Healthcare Partners LLC | 93,500 | $2,186,000 | 0.63% |
| Ranger Investment Management | 244,963 | $5,727,000 | 0.38% |
| CADENCE CAPITAL MANAGEMENT LLC | 107,043 | $2,503,000 | 0.27% |
| ALGERT GLOBAL LLC | 29,652 | $693,000 | 0.21% |
| Mondrian Investment Partners LTD | 163,939 | $3,833,000 | 0.10% |
| NAVELLIER & ASSOCIATES INC | 20,800 | $486,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 56,811 | $1,328,000 | 0.04% |